Advertisement

Tumor Biology

, Volume 35, Issue 4, pp 3439–3445 | Cite as

GSTM1 null genotype is associated with increased risk of gastric cancer in both ever-smokers and non-smokers: a meta-analysis of case–control studies

  • Jianchun Gu
  • Hanqing Zou
  • Leizhen Zheng
  • Xiaoping Li
  • Siyu Chen
  • Li Zhang
Research Article

Abstract

Previous studies have suggested that the glutathione S-transferases M1 (GSTM1) null genotype is associated with the risk of gastric cancer. However, the interaction between GSTM1 null genotype and smoking for the risk of gastric cancer is still elusive. Therefore, we performed a meta-analysis to ascertain this issue. Databases of PubMed, EMBASE, and China National Knowledge Infrastructure were searched to retrieve relevant studies. Smokers were categorized as “ever-smokers” and “non-smokers.” Odds ratios (ORs) and 95 % confidence intervals (95 % CIs) were calculated to estimate the association strength. Subgroup analyses according to ethnicity, source of control, and sample size were also conducted. A total of 15 eligible studies, including 4,687 gastric cancer cases and 7,002 controls, were identified. We found that the GSTM1 null genotype was associated with increased risk of gastric cancer among ever-smokers (OR = 1.460, 95 % CI 1.064–2.003, heterogeneity: P = 0.019). The null genotype also significantly increased the risk of gastric cancer among non-smokers (OR = 1.777, 95 % CI 1.301–2.426, heterogeneity: P < 0.01). Stratified analysis according to ethnicity showed that the GSTM1 null genotype was associated with increased risk of gastric cancer among Asians both in ever-smokers (OR = 1.841, 95 % CI 1.184–2.861) and non-smokers (OR = 1.773, 95 % CI 1.382–2.275). In conclusion, the GSMT1 null genotype significantly increased the risk of gastric cancer both in ever-smokers and non-smokers.

Keywords

GSTM1 Null genotype Gastric cancer Smoking 

Notes

Conflicts of interest

None.

References

  1. 1.
    Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med. 1995;333(1):32–41.PubMedCrossRefGoogle Scholar
  2. 2.
    Bhabak KP, Mugesh G. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc Chem Res. 2010;43(11):1408–19.PubMedCrossRefGoogle Scholar
  3. 3.
    Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res. 1988;202(2):343–61.PubMedCrossRefGoogle Scholar
  4. 4.
    Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445–600.PubMedCrossRefGoogle Scholar
  5. 5.
    Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271–6.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17(9):1855–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, et al. The human glutathione S-transferases: a case–control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis. 1991;12(1):25–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Qiu LX, Wang K, Lv FF, Chen ZY, Liu X, Zheng CL, et al. GSTM1 null allele is a risk factor for gastric cancer development in Asians. Cytokine. 2011;55(1):122–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Zhuo WL, Zhang YS, Wang Y, Zhuo XL, Zhu B, Cai L, et al. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Arch Med Res. 2009;40(3):169–79.PubMedCrossRefGoogle Scholar
  12. 12.
    Malakar M, Devi KR, Phukan RK, Kaur T, Deka M, Puia L, et al. Genetic polymorphism of glutathione S-transferases M1 and T1, tobacco habits and risk of stomach cancer in Mizoram. India Asian Pac J Cancer Prev. 2012;13(9):4725–32.CrossRefGoogle Scholar
  13. 13.
    García-González MA, Quintero E, Bujanda L, Nicolas D, Benito R, Strunk M, et al. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis. 2012;27(6):771–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Zendehdel K, Bahmanyar S, McCarthy S, Nyren O, Andersson B, Ye W. Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers. Cancer Causes Control. 2009;20(10):2031–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer. 2009;40(1–2):26–32.PubMedCrossRefGoogle Scholar
  16. 16.
    Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, et al. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case–control study in an Italian population. BMC Cancer. 2007;7:206.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Agudo A, Sala N, Pera G, Capella G, Berenguer A, Garcia N, et al. No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2006;15(5):1043–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Shen J, Wang RT, Xu YC, Wang LW, Wang XR. Interaction models of CYP1A1, GSTM1 polymorphisms and tobacco smoking in intestinal gastric cancer. World J Gastroenterol. 2005;11(38):6056–60.PubMedGoogle Scholar
  19. 19.
    Li H, Chen XL, Li HQ. Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol. 2005;11(37):5757–62.PubMedGoogle Scholar
  20. 20.
    Tamer L, Ates NA, Ates C, Ercan B, Elipek T, Yildirim H, et al. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct. 2005;23(4):267–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Shen J, Wang R, Xu X. [Application of the interaction models between the polymorphism(s) of metabolic gene (s) and environmental exposure]. Zhonghua Liu Xing Bing Xue Za Zhi. 2001;22(1):61–4.Google Scholar
  22. 22.
    Cai L, Yu SZ, Zhang ZF. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case–control study. World J Gastroenterol. 2001;7(4):506–9.PubMedGoogle Scholar
  23. 23.
    Jing C, Huang ZJ, Duan YQ, Wang PH, Zhang R, Luo KS, et al. Glulathione-S-transferases gene polymorphism in prediction of gastric cancer risk by smoking and Helicobacter pylori infection status. Asian Pac J Cancer Prev. 2012;13(7):3325–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Zhang AP, Liu BH, Wang L, Gao Y, Li F, Sun SX. Glutathione S-transferase gene polymorphisms and risk of gastric cancer in a Chinese population. Asian Pac J Cancer Prev. 2011;12(12):3421–5.PubMedGoogle Scholar
  25. 25.
    Piao JM, Shin MH, Kweon SS, Kim HN, Choi JS, Bae WK, et al. Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol. 2009;15(45):5716–21.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (Gstm1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 1993;85(14):1159–64.PubMedCrossRefGoogle Scholar
  27. 27.
    Miller 3rd MC, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett. 2001;120(1–3):269–80.PubMedCrossRefGoogle Scholar
  28. 28.
    Cohn LD, Becker BJ. How meta-analysis increases statistical power. Psychol Methods. 2003;8(3):243–53.PubMedCrossRefGoogle Scholar
  29. 29.
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1–1438.Google Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Jianchun Gu
    • 1
  • Hanqing Zou
    • 2
  • Leizhen Zheng
    • 1
  • Xiaoping Li
    • 1
  • Siyu Chen
    • 1
  • Li Zhang
    • 1
  1. 1.Department of OncologyXinhua Hospital Affiliated to Shanghai Jiaotong University School of MedicineShanghaiChina
  2. 2.Department of General SurgeryThe Second Affiliated Hospital of Soochow UniversitySuzhouChina

Personalised recommendations